Development of a nanoscale screening assay for the rapid optimisation of biopharmaceuticals
Biopharmaceutical development is often delayed in part by the extensive stability analysis and formulation refinement entailed in the early stages. Determination of a suitable therapeutic protein or peptide and the ideal formulation requires consideration of t he delivery route, dose and the stabili...
Main Author: | |
---|---|
Published: |
University of Nottingham
2014
|
Subjects: | |
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.755823 |